Brief: Cns Pharmaceuticals Announces Reverse Stock Split
Nov 28 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT
* CO ANNOUNCED A 1-FOR-30 REVERSE SPLIT OF ITS COMMON STOCK
* CBEGINNING ON NOV 29, CO'S COMMON STOCK WILL CONTINUE TO
TRADE
ON NASDAQ ON SPLIT ADJUSTED BASIS UNDER TRADING SYMBOL "CNSP"
Source text for Eikon: ID:nPnbJLg8sa
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026